Lidocaine Injections for Abdominal Pain
Trial Summary
What is the purpose of this trial?
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
Eligibility Criteria
This trial is for adults with chronic abdominal pain who have a positive Carnett's sign or pain near an incisional site, and suspect their pain is from the abdominal wall. They must be over 18, not pregnant, able to consent, and without severe allergies to lidocaine or bleeding disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline assessment includes medical history review, survey administration, and Quantitative Sensory Testing
Treatment
Participants receive abdominal wall injections with lidocaine
Follow-up
Participants are monitored for changes in abdominal wall pain at 1 week, 4 weeks, and 12 weeks following the injection
Treatment Details
Interventions
- Abdominal wall injections with lidocaine 2%
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor